Leitlinie „Behandlung der Akne“ - AWMF
Leitlinie „Behandlung der Akne“ - AWMF
Leitlinie „Behandlung der Akne“ - AWMF
Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.
YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.
013/017 - Behandlung <strong>der</strong> Akne aktueller Stand: 02/2010<br />
korrigierte Fassung: 10/2011<br />
320. Redmond GP, Olson WH, Lippman JS, Kafrissen ME, Jones TM, Jorizzo JL.<br />
Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized,<br />
placebo-controlled trial. Obstet Gynecol. 1997; 89: 615-22.<br />
321. Sator PG, Schmidt JB, Honigsmann H. Clinical evidence of the endocrinological<br />
influence of a triphasic oral contraceptive containing norgestimate and ethinyl<br />
estradiol in treating women with acne vulgaris. A pilot study. Dermatology. 2003;<br />
206: 241-8.<br />
322. Katz HI, Kempers S, Akin MD, Dunlap F, Whiting D, Norbart TC. Effect of a<br />
desogestrel-containing oral contraceptive on the skin. Eur J Contracept Reprod Health<br />
Care. 2000; 5: 248-55.<br />
323. Vree ML, Schmidt J. A large observational clinical evaluation of a desogestrelcontaining<br />
combiphasic oral contraceptive in Germany. Eur J Contracept Reprod<br />
Health Care. 2001; 6: 108-14.<br />
324. Rosenberg MJ, Meyers A, Roy V. Efficacy, cycle control, and side effects of low- and<br />
lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35<br />
micrograms estrogen preparations. Contraception. 1999; 60: 321-9.<br />
325. Winkler UH, Ferguson H, Mul<strong>der</strong>s JA. Cycle control, quality of life and acne with<br />
two low-dose oral contraceptives containing 20 microg ethinylestradiol.<br />
Contraception. 2004; 69: 469-76.<br />
326. Rosen MP, Breitkopf DM, Nagamani M. A randomized controlled trial of secondversus<br />
third-generation oral contraceptives in the treatment of acne vulgaris. Am J<br />
Obstet Gynecol. 2003; 188: 1158-60.<br />
327. Pierard-Franchimont C, Gaspard U, Lacante P, Rhoa M, Slachmuyl<strong>der</strong>s P, Pierard<br />
GE. A quantitative biometrological assessment of acne and hormonal evaluation in<br />
young women using a triphasic low-dose oral contraceptive containing gestodene. Eur<br />
J Contracept Reprod Health Care. 2000; 5: 275-86.<br />
328. Halbe HW, de Melo NR, Bahamondes L, Petracco A, Lemgruber M, de Andrade RP,<br />
da Cunha DC, Guazelli CA, Baracat EC. Efficacy and acceptability of two<br />
monophasic oral contraceptives containing ethinylestradiol and either desogestrel or<br />
gestodene. Eur J Contracept Reprod Health Care. 1998; 3: 113-20.<br />
329. Koetsawang S, Charoenvisal C, Banharnsupawat L, Singhakovin S, Kaewsuk O,<br />
Punnahitanont S. Multicenter trial of two monophasic oral contraceptives containing<br />
30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.<br />
Contraception. 1995; 51: 225-9.<br />
330. Mango D, Ricci S, Manna P, Miggiano GA, Serra GB. Clinical and hormonal effects<br />
of ethinylestradiol combined with gestodene and desogestrel in young women with<br />
acne vulgaris. Contraception. 1996; 53: 163-70.<br />
331. Maloney M, Arbit D, Flack M, McLaughlin-Miley C, Sevilla C, Derman R. Use of a<br />
low-dose oral contraceptive containing norethindrone acetate and ethinyl estradiol in<br />
the treatment of mo<strong>der</strong>ate acne vulgaris. Clin J Women's Health. 2001; 1: 124-31.<br />
332. Thorneycroft IH, Stanczyk FZ, Bradshaw KD, Ballagh SA, Nichols M, Weber ME.<br />
Effect of low-dose oral contraceptives on androgenic markers and acne.<br />
Contraception. 1999; 60: 255-62.<br />
333. Parkin L, Skegg DC, Wilson M, Herbison GP, Paul C. Oral contraceptives and fatal<br />
pulmonary embolism. Lancet. 2000; 355: 2133-4.<br />
Seite 126 von 136
Change language